RECOMBINANT ANTIBODIES COMPRISING ANTI-HUMAN IMMUNOGLOBULIN G-INVERTASE FUSION PROTEINS AND METHODS OF USING THE SAME

RECOMBINANT ANTIBODIES COMPRISING ANTI-HUMAN IMMUNOGLOBULIN G-INVERTASE FUSION PROTEINS AND METHODS OF USING THE SAME

The present disclosure relates to recombinant antibodies comprising anti-human immunoglobulin G (IgG)-invertase fusion proteins (also called "recombinant antibody fusion proteins"), kits comprising the same, and methods of using the same. The recombinant antibody fusion proteins permit det...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SPANGLER, Jamie, JUELG, Boris D, ARROYO, Netzahualcoyotl, LEONARD, Elissa Kathleen, ALLER PELLITERO, Miguel
Format: Patent
Sprache:eng ; fre
Schlagworte:
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure relates to recombinant antibodies comprising anti-human immunoglobulin G (IgG)-invertase fusion proteins (also called "recombinant antibody fusion proteins"), kits comprising the same, and methods of using the same. The recombinant antibody fusion proteins permit detection of antibodies to a broad array of antigenic polypeptides, such as a polypeptide of an infectious pathogen or a human polypeptide known to associate with autoimmune diseases or disorders in a quick, reliable, and affordable immunoassay using personal glucometers. La présente invention concerne des anticorps recombinants comprenant des protéines de fusion anti-immunoglobuline G (IgG)-invertase humaine (également appelées "protéines de fusion d'anticorps recombinant"), des kits les comprenant, et des procédés d'utilisation de ceux-ci. Les protéines de fusion d'anticorps recombinant permettent la détection d'anticorps dirigés contre un large réseau de polypeptides antigéniques, tels qu'un polypeptide d'un pathogène infectieux ou un polypeptide humain connu pour s'associer à des maladies ou des troubles auto-immuns dans un dosage immunologique rapide, fiable et abordable à l'aide de glucomètres personnels.